An Open-Label Phase I/II Trial Investigating DEP Cabazitaxel in Patients with Advanced Solid Tumours
Phase of Trial: Phase I/II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2018 According to a Starpharma media release, two UK sites have been already activated for recruitment and additional sites to follow in the expansion phase.
- 26 Feb 2018 Status changed from not yet recruiting to recruiting, according to a Starpharma media release.
- 31 Jan 2018 Status changed from planning to not yet recruiting according to a Starpharma media release.